Pilot Study of APD209 in Cancer Cachexia

NCT00895726 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer-related Cachexia

Interventions

DRUG: APD209

Sponsor

Acacia Pharma Ltd